PaxMedica, Inc. Common Stock
PaxMedica, Inc. Common Stock (PXMD) Stock Overview
Explore PaxMedica, Inc. Common Stock’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
63.1K
P/E Ratio
-0.00
EPS (TTM)
$2.44
ROE
-10.47%
PXMD Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of PaxMedica, Inc. Common Stock (PXMD) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 39.11, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.00 and a market capitalization of 63.1K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.